Terms: = Liver cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
31 results:
1. Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST.
Dai Z; Wang S; Guo X; Wang Y; Yin H; Tan J; Mu C; Sun SH; Liu H; Yang F
Clin Transl Med; 2023 Dec; 13(12):e1518. PubMed ID: 38148658
[TBL] [Abstract] [Full Text] [Related]
2. NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication.
Feng J; Xu T; He M; Li J; Yao P; Ma C; Yang S; Xu Z; Yan K; Chen X; Wang H; Liu J; Zeng C; Xia Y; Yan H; Zhou L; Chen Y
PLoS Pathog; 2023 Dec; 19(12):e1011808. PubMed ID: 38048324
[TBL] [Abstract] [Full Text] [Related]
3. Allosterically inhibited PFKL via prostaglandin E2 withholds glucose metabolism and ovarian cancer invasiveness.
Chen S; Wu Y; Gao Y; Wu C; Wang Y; Hou C; Ren M; Zhang S; Zhu Q; Zhang J; Yao Y; Huang M; Qi YB; Liu XS; Horng T; Wang H; Ye D; Zhu Z; Zhao S; Fan G
Cell Rep; 2023 Oct; 42(10):113246. PubMed ID: 37831605
[TBL] [Abstract] [Full Text] [Related]
4. NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
Sun GF; Ding H
Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
6. Targeting NAD
Sun Q; Shen M; Zhu S; Liao Y; Zhang D; Sun J; Guo Z; Wu L; Xiao L; Liu L
Hepatol Int; 2023 Dec; 17(6):1444-1460. PubMed ID: 37204655
[TBL] [Abstract] [Full Text] [Related]
7. Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.
Zhou S; Liu Y; Zhang Q; Xu H; Fang Y; Chen X; Fu J; Yuan Y; Li Y; Yuan L; Xiang C
Stem Cell Res Ther; 2023 Apr; 14(1):58. PubMed ID: 37005657
[TBL] [Abstract] [Full Text] [Related]
8. Clonal haematopoiesis and dysregulation of the immune system.
Belizaire R; Wong WJ; Robinette ML; Ebert BL
Nat Rev Immunol; 2023 Sep; 23(9):595-610. PubMed ID: 36941354
[TBL] [Abstract] [Full Text] [Related]
9. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract] [Full Text] [Related]
10. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.
Guo XJ; Huang XY; Yang X; Lu JC; Wei CY; Gao C; Pei YZ; Chen Y; Sun QM; Cai JB; Zhou J; Fan J; Ke AW; Shi YG; Shen YH; Zhang PF; Shi GM; Yang GH
Cell Death Dis; 2023 Feb; 14(2):79. PubMed ID: 36732324
[TBL] [Abstract] [Full Text] [Related]
11. Distinct phenotypic spectra of hepatocellular carcinoma in liver-specific tumor suppressor-deficient hepatitis B virus transgenic mice.
Tarnow G; Matrenec R; Oropeza CE; Maienschein-Cline M; McLachlan A
Virology; 2022 Sep; 574():84-95. PubMed ID: 35961146
[TBL] [Abstract] [Full Text] [Related]
12. Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis.
Yu J; Gao G; Wang J; Zhao J; Zhang Y; Jiang D; Huang F
Comput Math Methods Med; 2022; 2022():4835417. PubMed ID: 35651922
[TBL] [Abstract] [Full Text] [Related]
13. Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma.
Lu Z; Liu R; Wang Y; Jiao M; Li Z; Wang Z; Huang C; Shi G; Ke A; Wang L; Fu Y; Xia J; Wen H; Zhou J; Wang X; Ye D; Fan J; Chu Y; Cai J
Hepatology; 2023 Mar; 77(3):745-759. PubMed ID: 35243663
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptional activation of S100A2 expression by HIF-1α via binding to the hypomethylated hypoxia response elements in HCC cells.
Yan J; Huang YJ; Huang QY; Liu PX; Wang CS
Mol Carcinog; 2022 May; 61(5):494-507. PubMed ID: 35107180
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic upregulation of tet2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma.
Yamashita H; Tourna A; Akita M; Itoh T; Chokshi S; Ajiki T; Fukumoto T; Youngson NA; Zen Y
Virchows Arch; 2022 May; 480(5):1077-1085. PubMed ID: 34905094
[TBL] [Abstract] [Full Text] [Related]
16. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
Pullarkat ST; Wu W; Pullarkat V
Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
[TBL] [Abstract] [Full Text] [Related]
17. miR-93-5p knockdown repressed hepatocellular carcinoma progression via increasing ERBB4 and TETs-dependent DNA demethylation.
Li Y; Wu B; Sun R; Zhao M; Li N
Autoimmunity; 2021 Dec; 54(8):547-560. PubMed ID: 34435526
[TBL] [Abstract] [Full Text] [Related]
18. Chronic alcohol exposure promotes HCC stemness and metastasis through
Chen D; Yan Y; Wang X; Li S; Liu Y; Yu D; He Y; Deng R; Liu Y; Xu M; Luo J; Gao H; Wang S
Aging (Albany NY); 2021 May; 13(10):14433-14455. PubMed ID: 34019487
[TBL] [Abstract] [Full Text] [Related]
19. DNA methylation as a key epigenetic player for hepatoblastoma characterization.
Rivas M; Aguiar T; Fernandes G; Lemes R; Caires-Júnior L; Goulart E; Telles-Silva K; Maschietto M; Cypriano M; de Toledo S; Carraro D; da Cunha I; da Costa C; Rosenberg C; Krepischi A
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101684. PubMed ID: 33852955
[TBL] [Abstract] [Full Text] [Related]
20. FGFR3
Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
[TBL] [Abstract] [Full Text] [Related]
[Next]
